Third Wave of Corona in India: advisory from AIIMS Director as Festive Season Nears


As the threat of a possible third wave looms large, Directors of All India Institute of Medical Sciences (AIIMS) across the country have asked people to continue following Covid appropriate behaviour to avoid any possible spike in the daily caseload. “Avoid stepping out of the house unless absolutely necessary.


Whenever you step out of the house, wear a mask. Keep washing your hands with soap. After touching anything, definitely use sanitiser. Health is important now”, said AIIMS, Delhi, Director, Dr Randeep Guleria as the festive season is approaching. He asserted that the Covid pandemic is not over yet and people need to be more cautious.


Dr Arvind Rajvanshi, AIIMS, Rae Bareli, Director said that if people strictly follow Covid-compliant behaviour, then surely a new Covid wave can be prevented. “People will have to follow Covid compliant behavior, wear masks properly, keep cleaning or sanitising hands continuously, avoid going to crowded places, and follow social distance to prevent the third wave.” The government is trying to make the vaccine accessible to all equally, he added.


One Antibody Neutralized Four Variants Of Concern


The antibodies were tested against four types of variants: alpha, beta, gamma, and delta. Twelve of the thirteen correctly identified alpha and delta, eight correctly identified all four variations, and one incorrectly identified any of the four variants. 2C08 was the antibody that neutralised all four of the concern variations, as well as three more variants tested independently.


Some people may have antibodies that are equally as effective as 2C08 in defending them from SARS-CoV-2 and its numerous variations, according to Ellebedy. The researchers determined that around 20% of persons infected or vaccinated against SARS-CoV-2 produce antibodies that identify the same location on the virus that 2C08 targets using publicly available data. Furthermore, only a small percentage of viral variations (.008%) have mutations that allow them to evade antibodies that target that region.